Cited by 1,425Brain Metastases and TreatmentManagement of metastatic bone diseaseCancer survivorship and care

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Open access

Sperduto, Paul W., Kased, Norbert, Roberge, David, Xu, Zhiyuan, Shanley, Ryan, Luo, Xianghua, Sneed, Penny K., Chao, Samuel T., Weil, Robert J., Suh, John, Bhatt, Amit, Jensen, Ashley W., Brown, Paul D., Shih, Helen A., Kirkpatrick, John, Gaspar, Laurie E., Fiveash, John B., Chiang, Veronica, Knisely, Jonathan P.S., Sperduto, Christina Maria, Lin, Nancy, Mehta, Minesh·2012·Journal of Clinical Oncology

DOI 10.1200/jco.2011.38.0527PMC PMC3269967

Open this paper in CoChat — free account

Abstract

PURPOSE: Our group has previously published the Graded Prognostic Assessment (GPA), a prognostic index for patients with brain metastases. Updates have been published with refinements to create diagnosis-specific Graded Prognostic Assessment indices. The purpose of this report is to present the updated diagnosis-specific GPA indices in a single, unified, user-friendly report to allow ease of access and use by treating physicians. METHODS: A multi-institutional retrospective (1985 to 2007) database of 3,940 patients with newly diagnosed brain metastases underwent univariate and multivariate analyses of prognostic factors associated with outcomes by primary site and treatment. Significant prognostic factors were used to define the diagnosis-specific GPA prognostic indices. A GPA of 4.0 correlates with the best prognosis, whereas a GPA of 0.0 corresponds with the worst prognosis. RESULTS: Significant prognostic factors varied by diagnosis. For lung cancer, prognostic factors were Karnofsky performance score, age, presence of extracranial metastases, and number of brain metastases, confirming the original Lung-GPA. For melanoma and renal cell cancer, prognostic factors were Karnofsky performance score and the number of brain metastases. For breast cancer, prognostic factors were tumor subtype, Karnofsky performance score, and age. For GI cancer, the only prognostic factor was the Karnofsky performance score. The median survival times by GPA score and diagnosis were determined. CONCLUSION: Prognostic factors for patients with brain metastases vary by diagnosis, and for each diagnosis, a robust separation into different GPA scores was discerned, implying considerable heterogeneity in outcome, even within a single tumor type. In summary, these indices and related worksheet provide an accurate and facile diagnosis-specific tool to estimate survival, potentially select appropriate treatment, and stratify clinical trials for patients with brain metastases.

Integrity signals

Registry

Crossref · 10.1200/jco.2011.38.0527

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,858
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
Gaspar, L. E., Scott, C., Rotman, M., Asbell, S. O., Phillips, T. L., Wasserman, T. H., McKenna, W. G., & Byhardt, R. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,548
Self-citation
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
Sperduto, P. W., Berkey, B. A., Gaspar, L. E., Mehta, M. P., & Curran, W. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Self-citation
An Introduction to Recursive Partitioning Using the RPART Routines
Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987
Self-citation
Intracerebral metastases in solid-tumor patients: Natural history and results of treatment
Zimm, S., Wampler, G. L., Stablein, D., Hazra, T. A., & Young, H. F. (1981) · Cancer · doi:10.1002/1097-0142(19810715)48:2 · Cited by 597
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases
Gaspar, L. E., Scott, C., Murray, K., & Curran, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 531
Self-citation
Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J. H., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.027 · Cited by 367
Self-citation

Flagged first, then by citations

Show all 21 references

Research works printed but not linked: 1

Therneau TM, 1997, Technical Report 61

Sorted by citations

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Novello, S., Barlesi, F., Califano, R., Cufer, T., Ekman, S., Levra, M. G., Kerr, K., Popat, S., Reck, M., Senan, S., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw326 · Cited by 2,631
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
Japanese Society for Cancer of the Colon and Rectum, Watanabe, T., Muro, K., Ajioka, Y., Hashiguchi, Y., Ito, Y., Saito, Y., Hamaguchi, T., Ishida, H., Ishiguro, M., et al. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1101-6 · Cited by 2,467
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Planchard, D., Popat, S., Kerr, K., Novello, S., Smit, E. F., Faivre-Finn, C., Mok, T. S., Reck, M., Van Schil, P. E., Hellmann, M. D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy275 · Cited by 2,274
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Hashiguchi, Y., Muro, K., Saitō, Y., Ito, Y., Ajioka, Y., Hamaguchi, T., Hasegawa, K., Hotta, K., Ishida, H., Ishiguro, M., et al. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01485-z · Cited by 1,950
CNS Metastases in Breast Cancer: Old Challenge, New Frontiers
Lin, N., Amiri‐Kordestani, L., Palmieri, D., Liewehr, D. J., & Steeg, P. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0790 · Cited by 1,292
Self-citation
Brain metastases
Achrol, A. S., Rennert, R. C., Anders, C. K., Soffietti, R., Ahluwalia, M. S., Nayak, L., Peters, S., Arvold, N. D., Harsh, G. R., Steeg, P. S., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0055-y · Cited by 1,201
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Peters, S., Adjei, A. A., Gridelli, C., Reck, M., Kerr, K. M., & Felip, E. (2012) · Annals of Oncology · doi:10.1093/annonc/mds226 · Cited by 939
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
Brown, P. D., Gondi, V., Pugh, S. L., Tomé, W. A., Wefel, J. S., Armstrong, T. S., Bovi, J. A., Robinson, C. G., Konski, A. A., Khuntia, D., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02767 · Cited by 862
Self-citation
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
Mahajan, A., Ahmed, S., McAleer, M. F., Weinberg, J. S., Li, J., Brown, P. D., Settle, S. H., Prabhu, S. S., Lang, F. F., Levine, N. B., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30414-x · Cited by 801
Self-citation
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Reck, M., Popat, S., Reinmuth, N., Ruysscher, D. D., Kerr, K. M., & Peters, S. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu199 · Cited by 689
Estimating Survival in Patients With Lung Cancer and Brain Metastases
Sperduto, P. W., Yang, J. T., Beal, K. P., Pan, H. Y., Brown, P. D., Bangdiwala, A. S., Shanley, R., Yeh, N., Gaspar, L. E., Braunstein, S. E., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3834 · Cited by 662
Self-citation
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
Bagley, S. J., Kothari, S., Aggarwal, C., Bauml, J. M., Alley, E. W., Evans, T. L., Kosteva, J. A., Ciunci, C. A., Gabriel, P. E., Thompson, J. C., et al. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.01.013 · Cited by 523
Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis
Minniti, G. C., Scaringi, C., Paolini, S., Lanzetta, G., Romano, A., Cicone, F., Osti, M. F., Enrici, R. M., & Esposito, V. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.03.013 · Cited by 485
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient
Sperduto, P. W., Mesko, S. M., Li, J., Cagney, D. N., Aizer, A. A., Lin, N., Nesbit, E. G., Kruser, T. J., Chan, J. W. S., Braunstein, S. E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01255 · Cited by 496
Self-citation
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
Vokes, E. E., Ready, N., Felip, E., Horn, L., Burgio, M. A., Antonia, S. J., Frontera, O. A., Gettinger, S. N., Holgado, E., Spigel, D. R., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy041 · Cited by 468
Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
Magnuson, W. J., Lester-Coll, N. H., Wu, A. J.-C., Yang, J. T., Lockney, N. A., Gerber, N. K., Beal, K. P., Amini, A., Patil, T., Kavanagh, B. D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.7144 · Cited by 462
Self-citation
Treatment of Brain Metastases
Lin, X., & DeAngelis, L. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.9503 · Cited by 452
Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation
Péus, D., Newcomb, N., & Höfer, S. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-72 · Cited by 437
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
Tsao, M. N., Lloyd, N. S., Wong, R. K. S., Chow, E., Rakovitch, E., Laperrière, N., Xu, W., & Sahgal, A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003869.pub3 · Cited by 434
Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline
Gondi, V., Bauman, G. S., Bradfield, L., Burri, S. H., Cabrera, A. R., Cunningham, D. A., Eaton, B. R., Hattangadi-Gluth, J. A., Kim, M. M., Kotecha, R. R., et al. (2022) · Practical Radiation Oncology · doi:10.1016/j.prro.2022.02.003 · Cited by 427
Self-citation
Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
Kiess, A. P., Wolchok, J. D., Barker, C. A., Postow, M. A., Tabar, V. S., Huse, J. T., Chan, T. A.-T., Yamada, Y. J., & Beal, K. P. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.01.004 · Cited by 393
Recent trends in epidemiology of brain metastases: an overview.
Tabouret, É., Chinot, O. L., Métellus, P., Tallet, A. R., Viens, P., & Gonçalvès, A. (2012) · PubMed · Cited by 355
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study
Tawbi, H. A., Forsyth, P. A., Hodi, F. S., Algazi, A. P., Hamid, O., Lao, C. D., Moschos, S. J., Atkins, M. B., Lewis, K., Postow, M. A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00545-3 · Cited by 359
Brain metastases: epidemiology
Ostrom, Q. T., Wright, C. H., & Barnholtz‐Sloan, J. S. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-12-811161-1.00002-5 · Cited by 334
Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis
Johung, K. L., Yeh, N., Desai, N. B., Williams, T. M., Lautenschlaeger, T., Arvold, N. D., Ning, M. S., Attia, A. A., Lovly, C. M., Goldberg, S. B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.0138 · Cited by 332
Self-citation
Brain Tumors
McFaline-Figueroa, J. R., & Lee, E. Q. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.12.039 · Cited by 299
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
Wu, Y.-L., Planchard, D., Lü, S., Sun, H., Yamamoto, N., Kim, D., Tan, D. S.-W., Yang, J. C., Azrif, M., Mitsudomi, T., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy554 · Cited by 294
Epidemiology of Brain Metastases
Sacks, P., & Rahman, M. (2020) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2020.06.001 · Cited by 288
Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450)
De Ruysscher, D., Wanders, R., van Baardwijk, A., Dingemans, A.-M. C., Reymen, B., Houben, R., Bootsma, G., Pitz, C., van Eijsden, L., Geraedts, W., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318262caf6 · Cited by 283
Updates in the management of brain metastases
Arvold, N. D., Lee, E. Q., Mehta, M. P., Margolin, K. A., Alexander, B. M., Lin, N., Anders, C. K., Soffietti, R., Camidge, D. R., Vogelbaum, M. A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now127 · Cited by 282
Self-citation
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320
Sperduto, P. W., Wang, M., Robins, H. I., Schell, M. C., Werner-Wasik, M., Komaki, R., Souhami, L., Buyyounouski, M. K., Khuntia, D., Demas, W., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.11.042 · Cited by 274
Self-citation
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
Kaufmann, T. J., Smits, M., Boxerman, J. L., Huang, R. Y., Barboriak, D. P., Weller, M., Chung, C. D., Tsien, C. I., Brown, P. D., Shankar, L. K., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa030 · Cited by 274
Self-citation
Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data
Lehrer, E. J., Peterson, J., Brown, P. D., Sheehan, J. P., Quiñones‐Hinojosa, A., Zaorsky, N. G., & Trifiletti, D. M. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.08.025 · Cited by 273
Self-citation
Role of Radiation Therapy in Palliative Care of the Patient With Cancer
Lutz, S., Jones, J., & Chow, E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1143 · Cited by 266
Treatment strategies for breast cancer brain metastases
Bailleux, C., Eberst, L., & Bachelot, T. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01175-y · Cited by 243
Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers
Berghoff, A. S., Schur, S., Füreder, L. M., Gatterbauer, B., Dieckmann, K. U., Widhalm, G., Hainfellner, J. A., Zielinski, C. C., Birner, P., Bartsch, R., et al. (2016) · ESMO Open · doi:10.1136/esmoopen-2015-000024 · Cited by 241
Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood–tumor barrier disruption
Arvanitis, C., Askoxylakis, V., Guo, Y., Datta, M., Kloepper, J., Ferraro, G. B., Bernabéu, M. O., Fukumura, D., McDannold, N. J., & Jain, R. K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807105115 · Cited by 235
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases
Rusthoven, C. G., Yamamoto, M., Bernhardt, D., Smith, D. E., Gao, D., Serizawa, T., Yomo, S., Aiyama, H., Higuchi, Y., Shuto, T., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.1271 · Cited by 226
Self-citation
Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases
Aoyama, H., Tago, M., & Shirato, H. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1145 · Cited by 220
Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma
Chamberlain, M. C., Baik, C. S., Gadi, V. K., Bhatia, S., & Chow, L. Q. M. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now197 · Cited by 222
CAR T cells for brain tumors: Lessons learned and road ahead
Akhavan, D., Alizadeh, D., Wang, D., Weist, M. R., Shepphird, J. K., & Brown, C. E. (2019) · Immunological Reviews · doi:10.1111/imr.12773 · Cited by 217
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
Sperduto, P. W., Jiang, W., Brown, P. D., Braunstein, S. E., Sneed, P. K., Wattson, D. A., Shih, H. A., Bangdiwala, A. S., Shanley, R., Lockney, N. A., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.06.2454 · Cited by 210
Self-citation
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
Tsao, M. N., Xu, W., Wong, R. K. S., Lloyd, N. S., Laperrière, N., Sahgal, A., Rakovitch, E., & Chow, E. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003869.pub4 · Cited by 207
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer
Tolaney, S. M., Sahebjam, S., Rhun, É. L., Bachelot, T., Kabos, P., Awada, A. H., Yardley, D. A., Chan, A., Conte, P., Dieras, V. C., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1764 · Cited by 203
Self-citation
Stereotactic radiosurgery for treatment of brain metastases
Köcher, M., Wittig, A., Piroth, M. D., Treuer, H., Seegenschmiedt, H. M., Ruge, M. I., Grosu, A., & Gückenberger, M. (2014) · Strahlentherapie und Onkologie · doi:10.1007/s00066-014-0648-7 · Cited by 197
Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery
Baschnagel, A. M., Meyer, K., Chen, P. Y., Krauss, D. J., Olson, R. E., Pieper, D. R., Maitz, A. H., Ye, H., & Grills, I. S. (2013) · Journal of neurosurgery · doi:10.3171/2013.7.jns13431 · Cited by 196
Fractionated stereotactic radiosurgery for patients with brain metastases
Minniti, G. C., D’Angelillo, R. M., Scaringi, C., Trodella, L. E., Clarke, E., Matteucci, P., Osti, M. F., Ramella, S., Enrici, R. M., & Trodella, L. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1388-3 · Cited by 189
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
Griesinger, F., Curigliano, G., Thomas, M., Subbiah, V., Baik, C. S., Tan, D. S. W., Lee, D., Misch, D., Garralda, E., Kim, D.-W., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.08.002 · Cited by 186
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
Corbin, K. S., Hellmän, S., & Weichselbaum, R. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.9651 · Cited by 185
Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis
Niikura, N., Hayashi, N., Masuda, N., Takashima, S., Nakamura, R., Watanabe, K., Kanbayashi, C., Ishida, M., Hozumi, Y., Tsuneizumi, M., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3090-8 · Cited by 182
Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
Yang, J., Zhou, C., Huang, Y.-S., Feng, J., Sun, L., Song, Y., Huang, C., Wu, G., Zhang, L., Cheng, Y., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30262-x · Cited by 181
Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA)
Sperduto, P. W., Shanley, R., Luo, X., Andrews, D. W., Werner‐Wasik, M., Valicenti, R. K., Bahary, J.-P., Souhami, L., Won, M., & Mehta, M. P. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.07.002 · Cited by 174
Self-citation
Management of brain metastases according to molecular subtypes
Soffietti, R., Ahluwalia, M. S., Lin, N., & Rudà, R. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0391-x · Cited by 175
Self-citation
Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
Freedman, R. A., Gelman, R. S., Wefel, J. S., Melisko, M., Hess, K. R., Connolly, R. M., Poznak, C. H. V., Niravath, P. A., Puhalla, S. L., Ibrahim, N. K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0343 · Cited by 172
Self-citation
Defining the Optimal Planning Target Volume in Image-Guided Stereotactic Radiosurgery of Brain Metastases: Results of a Randomized Trial
Kirkpatrick, J. P., Wang, Z., Sampson, J. H., McSherry, F., Herndon, J. E., Allen, K. J., Duffy, E. A., Hoang, J. K., Chang, Z., Yoo, D. S., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.09.004 · Cited by 171
Self-citation
Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis
Miller, J. A., Bennett, E., Xiao, R., Kotecha, R. R., Chao, S. T., Vogelbaum, M. A., Barnett, G. H., Angelov, L., Murphy, E. S., Yu, J. S., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.08.039 · Cited by 169
Self-citation
Molecular and cellular mechanisms underlying brain metastasis of breast cancer
Hosonaga, M., Saya, H., & Arima, Y. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09881-y · Cited by 163
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
Sperduto, P. W., Kased, N., Roberge, D., Chao, S. T., Shanley, R., Luo, X., Sneed, P. K., Suh, J. H., Weil, R. J., Jensen, A. W., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1083-9 · Cited by 160
Self-citation
Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
Soliman, H., Das, S., Larson, D. A., & Sahgal, A. (2016) · Oncotarget · doi:10.18632/oncotarget.7131 · Cited by 162
Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience
Hughes, R. T., Masters, A. H., McTyre, E., Farris, M. K., Chung, C. D., Page, B. R., Kleinberg, L. R., Hepel, J. T., Contessa, J. N., Chiang, V., et al. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.03.052 · Cited by 154
Self-citation
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
Zimmermann, S., Dziadziuszko, R., & Peters, S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.03.005 · Cited by 147
Emerging Strategies for Treating Brain Metastases from Breast Cancer
Kodack, D. P., Askoxylakis, V., Ferraro, G. B., Fukumura, D., & Jain, R. K. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.01.001 · Cited by 149
AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013
Harbeck, N., Scharl, A. J., Thomssen, C., & Müller, V. (2013) · Breast Care · doi:10.1159/000353590 · Cited by 146
Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today
Sperduto, P. W., Mesko, S. M., Li, J., Cagney, D. N., Aizer, A. A., Lin, N., Nesbit, E. G., Kruser, T. J., Chan, J. W. S., Braunstein, S. E., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.01.051 · Cited by 148
Self-citation
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group
Lin, N., Wefel, J. S., Lee, E. Q., Schiff, D., van den Bent, M. J., Soffietti, R., Suh, J. H., Vogelbaum, M. A., Mehta, M. P., Dancey, J. E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70308-5 · Cited by 142
Self-citation
EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases
Jiang, T., Su, C., Li, X., Zhao, C., Zhou, F., Ren, S., Zhou, C., & Zhang, J. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.013 · Cited by 140
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis
Zagouri, F., Sergentanis, T. Ν., Bartsch, R., Berghoff, A. S., Chrysikos, D., de Azambuja, E., Dimopoulos, M. A., & Preusser, M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2525-y · Cited by 133
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases
Dudnik, E., Yust‐Katz, S., Nechushtan, H., Goldstein, D. A., Zer, A., Flex, D., Siegal, T., & Peled, N. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.05.031 · Cited by 134
Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors
Sperduto, P. W., De, B. S., Li, J., Carpenter, D. J., Kirkpatrick, J. P., Milligan, M., Shih, H. A., Kütük, T., Kotecha, R. R., Higaki, H., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.03.020 · Cited by 134
Self-citation
Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)
Berghoff, A. S., Ricken, G., Wilhelm, D., Rajky, O., Widhalm, G., Dieckmann, K. U., Birner, P., Bartsch, R., & Preusser, M. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2216-8 · Cited by 131
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
Lin, N., Lee, E. Q., Aoyama, H., Barani, I. J., Baumert, B. G., Brown, P. D., Camidge, D. R., Chang, S. M., Dancey, J. E., Gaspar, L. E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70311-5 · Cited by 130
Self-citation
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Brain Metastases Working Group
Lin, N., Prowell, T. M., Tan, A. R., Kozak, M., Rosen, O., Amiri‐Kordestani, L., White, J. R., Sul, J., Perkins, L. M., Beal, K., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.0761 · Cited by 128
Self-citation
Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases: Table 1
McDuff, S. G. R., Taich, Z. J., Lawson, J. D., Sanghvi, P. R., Wong, E. T., Barker, F. G., Hochberg, F. H., Loeffler, J. S., Warnke, P. C., Murphy, K. T., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305166 · Cited by 127
Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases
Ahmed, K. A., Kim, S., Arrington, J. A., Naghavi, A. O., Dilling, T. J., Creelan, B., Antonia, S. J., Caudell, J. J., Harrison, L. B., Sahebjam, S., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2437-5 · Cited by 127
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Harter, P. N., Bernatz, S., Scholz, A., Zeiner, P. S., Zinke, J., Kiyose, M., Blasel, S., Beschorner, R., Senft, C., Bender, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5696 · Cited by 125
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
Minniti, G. C., Anzellini, D., Reverberi, C., Cappellini, G. C. A., Marchetti, L., Bianciardi, F., Bozzao, A., Osti, M. F., Gentile, P. C., & Esposito, V. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0588-y · Cited by 123
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases
Furtner, J., Berghoff, A. S., Albtoush, O. M., Woitek, R., Asenbaum, U., Prayer, D., Widhalm, G., Gatterbauer, B., Dieckmann, K. U., Birner, P., et al. (2017) · European Radiology · doi:10.1007/s00330-016-4707-6 · Cited by 122
Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases
Subbiah, I. M., Lei, X. J., Weinberg, J. S., Sulman, E. P., Chávez‐MacGregor, M., Tripathy, D., Gupta, R., Varma, A., Chouhan, J. S., Guevarra, R. P., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8517 · Cited by 119
Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment
Anderson, E. S., Postow, M. A., Wolchok, J. D., Young, R. J., Ballangrud, Å., Chan, T. A.-T., Yamada, Y. J., & Beal, K. P. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0282-x · Cited by 120
Systemic treatment of brain metastases in non-small cell lung cancer
Page, S., Milner-Watts, C., Perna, M., Janžič, U., Vidal, N., Kaudeer, N., Ahmed, M., McDonald, F., Locke, I., Minchom, A. R., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.03.006 · Cited by 118
Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm
Angelov, L., Mohammadi, A. M., Bennett, E., Abbassy, M. A., Elson, P. J., Chao, S. T., Montgomery, J. S., Habboub, G., Vogelbaum, M. A., Suh, J. H., et al. (2017) · Journal of neurosurgery · doi:10.3171/2017.3.jns162532 · Cited by 117
Self-citation
Subtype switching in breast cancer brain metastases: a multicenter analysis
Hulsbergen, A. F. C., Claes, A., Kavouridis, V. K., Ansaripour, A., Nogarede, C. O., Hughes, M. E., Smith, T. R., Brastianos, P. K., Verhoeff, J. J. C., Lin, N., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa013 · Cited by 116
Self-citation
Karnofsky performance status before and after liver transplantation predicts graft and patient survival
Thuluvath, P. J., Thuluvath, A. J., & Savva, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.025 · Cited by 115
EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis
Soon, Y. Y., Leong, C. N., Koh, W. Y., & Tham, I. W. K. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.12.011 · Cited by 110
Tumour‐infiltrating lymphocytes and expression of programmed death ligand 1 (PD‐L1) in melanoma brain metastases
Berghoff, A. S., Ricken, G., Widhalm, G., Rajky, O., Dieckmann, K. U., Birner, P., Bartsch, R., Höeller, C., & Preusser, M. (2014) · Histopathology · doi:10.1111/his.12537 · Cited by 110
Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study
Habets, E. J. J., Dirven, L., Wiggenraad, R. G. J., Kanter, A. V.-D., Nijeholt, G. J. L. À., Zwinkels, H., Klein, M., & TAPHOORN, M. J. B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov186 · Cited by 110
Prophylactic cranial irradiation for patients with lung cancer
Pechoux, C. L., Sun, A. Y., Slotman, B. J., Ruysscher, D. D., Belderbos, J. S. A., & Gore, E. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30065-1 · Cited by 110
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors
Graber, J. J., Cobbs, C., & Olson, J. J. (2018) · Neurosurgery · doi:10.1093/neuros/nyy543 · Cited by 108
The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study
Wang, Y., Lang, J., Zuo, J. Z., Dong, Y., Hu, Z., Xu, X., Zhang, Y., Wang, Q., Yang, L., Wong, S. T. C., et al. (2022) · European Radiology · doi:10.1007/s00330-022-08887-0 · Cited by 108
Postoperative Stereotactic Radiosurgery Without Whole-Brain Radiation Therapy for Brain Metastases: Potential Role of Preoperative Tumor Size
Hartford, A. C., Paravati, A. J., Spire, W. J., Li, Z., Jarvis, L. A., Fadul, C. E., Rhodes, C. H., Erkmen, K., Friedman, J. M., Gladstone, D. J., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.05.027 · Cited by 107
Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database
Kim, Y., Js, K., & Kim, I. A. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2697-2 · Cited by 110
Palliative radiotherapy at the end of life: A critical review
Jones, J., Lutz, S., Chow, E., & Johnstone, P. A. S. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21242 · Cited by 106
Intracerebral efficacy and tolerance of nivolumab in non–small-cell lung cancer patients with brain metastases
Gauvain, C., Vauléon, E., CHOUAID, C., Rhun, É. L., Jabot, L., Scherpereel, A., Vinas, F., Cortot, A. B., & Monnet, I. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.12.008 · Cited by 105
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data
Dudnik, E., Moskovitz, M. T., Daher, S., Shamai, S., Hanovich, E., Grubstein, A., Shochat, T., Wollner, M., Bar, J., Merimsky, O., et al. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.11.015 · Cited by 106
Evolving treatment options for melanoma brain metastases
Ajithkumar, T., Parkinson, C., Fife, K. M., Corrie, P. G., & Jefferies, S. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00141-2 · Cited by 102
Targeting brain metastases in breast cancer
Corti, C., Antonarelli, G., Criscitiello, C., Lin, N., Carey, L., Cortés, J., Poortmans, P. M., & Curigliano, G. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102324 · Cited by 101
Self-citation
Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases
Magnuson, W. J., Yeung, J. T., Guillod, P., Gettinger, S. N., Yu, J. B., & Chiang, V. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.01.037 · Cited by 100
Self-citation
Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?
Toyokawa, G., Seto, T., Takenoyama, M., & Ichinose, Y. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9592-y · Cited by 99
Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer
Li, L., Luo, S., Lin, H., Yang, H., Chen, H., Liao, Z., Lin, W., Zheng, W., & Xie, X. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.07.57 · Cited by 97
Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma
Gerber, N. K., Yamada, Y., Rimner, A., Shi, W., Riely, G. J., Beal, K., Yu, H. A., Chan, T. A., Zhang, Z., & Wu, A. J. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.02.022 · Cited by 96

Authors: Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H. A., Kirkpatrick, J., Gaspar, L. E., Fiveash, J. B., Chiang, V., Knisely, J. P. S., Sperduto, C. M., Lin, N., & Mehta, M.
Affiliations: University of Minnesota (US)
University of California, San Francisco (US)
McGill University (CA)
Cleveland Clinic (US)
Author affiliations appear at the end of this article.
Mayo Clinic (US)
Harvard University (US)
Duke University (US)
University of Colorado Denver (US)
University of Alabama at Birmingham (US)
Yale University (US)
Hofstra University (US)
Dartmouth College (US)
Northwestern University (US)
ORCID: Sperduto, Paul W.
Kased, Norbert
Roberge, David
Xu, Zhiyuan
Shanley, Ryan
Luo, Xianghua
Sneed, Penny K.
Chao, Samuel T.
Weil, Robert J.
Suh, John
Bhatt, Amit
Brown, Paul D.
Shih, Helen A.
Kirkpatrick, John
Fiveash, John B.
Chiang, Veronica
Knisely, Jonathan P.S.
Mehta, Minesh
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2012-02-01
Volume: 30
Issue: 4
Pages: 419-425
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2011.38.0527
PMC: PMC3269967
OpenAlex: W1974820090
Cited by: 1,425
References: 21
Citations by year: 2026: 41 · 2025: 57 · 2024: 88 · 2023: 112 · 2022: 103 · 2021: 113 · 2020: 146 · 2019: 117 · 2018: 131 · 2017: 134 · 2016: 115 · 2015: 94 · 2014: 68 · 2013: 62 · 2012: 38
FWCI: 45.80
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Journal of Clinical Oncology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P30CA-77598, P30CA077598)
Topics: Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
Health Sciences › Medicine › Surgery › Management of metastatic bone disease
Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords: brain metastases, Graded Prognostic Assessment, prognosis, survival estimation, prognostic factors, lung cancer, melanoma, renal cell carcinoma, breast cancer, gastrointestinal cancer, Karnofsky performance status, extracranial metastases, number of brain metastases, clinical trial stratification
MeSH terms: Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Female, Humans, Kidney Neoplasms, Lung Neoplasms, Male, Melanoma, Neoplasm Metastasis, Prognosis, Retrospective Studies, Survival Analysis, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks